Filed Nov 6, 2026Period of report Nov 4, 20260001193125-26-452132
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 6, 2026
Common StockF2F3F4F6F7F8
60,400
$383.015
$23.13M
2,024,942
IndirectSee Footnotes
PurchaseNov 6, 2026
Common StockF2F3F4F6F7F8
13,740
$388.29
$5.34M
2,038,682
IndirectSee Footnotes
PurchaseNov 6, 2026
Common StockF2F3F4F6F7F8
2,000
$396.61
$793.22K
2,040,682
IndirectSee Footnotes
PurchaseNov 4, 2026
Common StockF5F2F3F4F6F7F8
5,586
$366.9922
$2.05M
1,954,462
IndirectSee Footnotes
PurchaseNov 4, 2026
Common StockF9F2F3F4F6F7F8
10,080
$368.1134
$3.71M
1,964,542
IndirectSee Footnotes
Filing footnotes · 9
F1As a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, L.P. ("667"), Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in common stock ("Common Stock") of Madrigal Pharmaceuticals, Inc. (the "Issuer") reported in column 5 of Table I held directly by or held for the benefit of 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667.
F2Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to 667 and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds"). In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by the Funds or for the benefit of the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by the Funds or for the benefit of the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by the Funds or for the benefit of the Funds.
F3Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by or held for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
F4Includes beneficial ownership of 3,825 shares of Common Stock received from vested restricted stock units of the Issuer (each an "RSU") and 454 shares of Common Stock underlying unvested RSUs previously granted to each of Julian C. Baker, a managing member of the Adviser GP, and Dr. Raymond Cheong, a full-time employee of the Adviser, in their capacity as directors of the Issuer.
F5The price reported in Column 4 is a weighted average price. These shares of Common Stock were traded by Life Sciences in multiple transactions at prices ranging from $366.77 to $367.17, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.
F6Pursuant to the policies of the Adviser, the Adviser has voting and dispositive power over the non-qualified stock options exercisable solely into Common Stock ("Stock Options"), RSUs and any Common Stock received as a result of the exercise of Stock Options or vesting of RSUs.
F7Pursuant to the policies of the Adviser, Julian C. Baker and Dr. Cheong do not have a right to any of the Issuer's securities issued as compensation for their service on the board of directors of the Issuer and the Funds are entitled to an indirect proportionate pecuniary interest in such securities. The Funds each own an indirect proportionate pecuniary interest in the Stock Options and RSUs. Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the Stock Options, RSUs and any Common Stock acquired upon the exercise of Stock Options or vesting of RSUs (i.e. no direct pecuniary interest) issued as compensation for such service on the board of directors of the Issuer.
F8After giving effect to the transactions reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in Common Stock reported in column 5 of Table I held directly by or held for the benefit of Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences.
F9The price reported in Column 4 is a weighted average price. These shares were traded by Life Sciences in multiple transactions at prices ranging from $367.41 to $368.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.
Filed Sep 11, 2026Period of report Sep 9, 20260001628280-26-061581
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 11, 2026
Common StockF16F17
60
$533.0913
$31.99K
202,907
Direct
SaleSep 11, 2026
Common StockF16F18
106
$534.063
$56.61K
202,801
Direct
SaleSep 11, 2026
Common StockF16F19
218
$535.9435
$116.84K
202,583
Direct
SaleSep 11, 2026
Common StockF16F20
160
$537.6175
$86.02K
202,423
Direct
SaleSep 11, 2026
Common StockF16F21
687
$540.5857
$371.38K
201,736
Direct
SaleSep 11, 2026
Common StockF16F22
368
$541.6423
$199.32K
201,368
Direct
SaleSep 11, 2026
Common StockF16F23
1,202
$542.6032
$652.21K
200,166
Direct
SaleSep 11, 2026
Common StockF16F24
1,539
$544.024
$837.25K
198,627
Direct
SaleSep 11, 2026
Common StockF16F25
761
$544.8307
$414.62K
197,866
Direct
SaleSep 11, 2026
Common StockF16F26
120
$546.3767
$65.57K
197,746
Direct
SaleSep 9, 2026
Common StockF1F2
131
$527.8783
$69.15K
209,198
Direct
SaleSep 9, 2026
Common StockF1F3
347
$529.2671
$183.66K
208,851
Direct
SaleSep 9, 2026
Common StockF1F4
522
$530.2311
$276.78K
208,329
Direct
SaleSep 9, 2026
Common StockF1F5
368
$531.9897
$195.77K
207,961
Direct
SaleSep 9, 2026
Common StockF1F6
512
$533.0932
$272.94K
207,449
Direct
SaleSep 9, 2026
Common StockF1F7
396
$534.1964
$211.54K
207,053
Direct
SaleSep 9, 2026
Common StockF1F8
644
$535.2719
$344.72K
206,409
Direct
SaleSep 9, 2026
Common StockF1F9
1,040
$536.1123
$557.56K
205,369
Direct
SaleSep 9, 2026
Common StockF1F10
640
$537.1738
$343.79K
204,729
Direct
SaleSep 9, 2026
Common StockF1F11
520
$538.2971
$279.91K
204,209
Direct
SaleSep 9, 2026
Common StockF1F12
215
$539.0281
$115.89K
203,994
Direct
SaleSep 9, 2026
Common StockF1F13
505
$540.1909
$272.80K
203,489
Direct
SaleSep 9, 2026
Common StockF1F14
362
$541.6538
$196.08K
203,127
Direct
SaleSep 9, 2026
Common StockF1F15
160
$542.5475
$86.81K
202,967
Direct
Filing footnotes · 26
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.56, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.70 to $538.65, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.86 to $539.83, inclusive.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.86 to $540.47, inclusive.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.29 to $542.27, inclusive.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.42 to $542.68, inclusive.
F16These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026.
F17The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.76 to $533.64, inclusive.
F18The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.76 to $534.48, inclusive.
F19The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.52 to $536.02, inclusive.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.49 to $528.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F20The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.235 to $538.00, inclusive.
F21The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.97 to $540.90, inclusive.
F22The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.00 to $541.73, inclusive.
F23The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.11 to $543.02, inclusive.
F24The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.27 to $544.20, inclusive.
F25The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.38 to $545.32, inclusive.
F26The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.28 to $546.56, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.54 to $529.51, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.64 to $530.48, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.57 to $532.28, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.57 to $533.29, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.58 to $534.57, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.63 to $535.62, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.64 to $536.45, inclusive.
Filed Aug 20, 2026Period of report Aug 17, 20260001628280-26-058256
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 17, 2026
Common StockF1
664
$514.97
$341.94K
11,474
Direct
Filing footnotes · 1
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
Filed Jul 20, 2026Period of report Jul 17, 20260001628280-26-048919
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 20, 2026
Common StockF2F3
140
$542.7459
$75.98K
211,689
Direct
SaleJul 20, 2026
Common StockF2F4
110
$543.7929
$59.82K
211,579
Direct
SaleJul 20, 2026
Common StockF2F5
545
$544.714
$296.87K
211,034
Direct
SaleJul 20, 2026
Common StockF2F6
275
$545.7092
$150.07K
210,759
Direct
SaleJul 20, 2026
Common StockF2F7
269
$547.0788
$147.16K
210,490
Direct
SaleJul 20, 2026
Common StockF2F8
680
$547.698
$372.43K
209,810
Direct
SaleJul 20, 2026
Common StockF2F9
47
$548.8719
$25.80K
209,763
Direct
SaleJul 20, 2026
Common StockF2F10
153
$550.0138
$84.15K
209,610
Direct
SaleJul 20, 2026
Common StockF2
1
$550.72
$550.72
209,609
Direct
SaleJul 20, 2026
Common StockF2F11
280
$555.05
$155.41K
209,329
Direct
Filing footnotes · 12
F1On July 17, 2026, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 12. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2029, the sixth anniversary of the commencement of his employment with the Issuer.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.70 to $550.24, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.10, inclusive.
F12On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that could be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person was eligible to earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025, the second hurdle in December 2025 and the third and final hurdle reported on this line, all performance hurdles have been achieved. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.
F2The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover certain tax withholding obligations in connection with the Reporting Person earning 50,000 shares of common stock as described in Footnote 1 above. This sale was automatic and not at the discretion of the Reporting Person.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.22 to $543.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.26 to $544.25, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.31 to $545.28, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.31 to $546.29, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.37 to $547.35, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.40 to $548.29, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.42 to $549.39, inclusive.
Filed May 22, 2026Period of report May 22, 20260001628280-26-037830
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 22, 2026
Common StockF1F2
40
$506.675
$20.27K
27,657
Direct
SaleMay 22, 2026
Common StockF1F3
320
$508.242
$162.64K
27,337
Direct
SaleMay 22, 2026
Common StockF1F4
151
$510.3579
$77.06K
27,186
Direct
SaleMay 22, 2026
Common StockF1F5
610
$511.3967
$311.95K
26,576
Direct
SaleMay 22, 2026
Common StockF1F6
439
$512.5022
$224.99K
26,137
Direct
SaleMay 22, 2026
Common StockF1
40
$512.97
$20.52K
26,097
Direct
SaleMay 22, 2026
Common StockF1F7
343
$514.6691
$176.53K
25,754
Direct
SaleMay 22, 2026
Common StockF1F8
657
$515.9219
$338.96K
25,097
Direct
SaleMay 22, 2026
Common StockF1F9
723
$516.8658
$373.69K
24,374
Direct
SaleMay 22, 2026
Common StockF1F10
1,497
$517.5921
$774.84K
22,877
Direct
SaleMay 22, 2026
Common StockF1F11
782
$518.758
$405.67K
22,095
Direct
SaleMay 22, 2026
Common StockF1F12
80
$519.98
$41.60K
22,015
Direct
Filing footnotes · 12
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive.
Filed May 18, 2026Period of report May 18, 20260001628280-26-036078
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 18, 2026
Common StockF1
844
$515.90
$435.42K
11,075
Direct
Filing footnotes · 1
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
Filed Mar 6, 2026Period of report Mar 4, 20260001628280-26-015775
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF2
646
$431.94
$279.03K
13,826
Direct
SaleMar 6, 2026
Common StockF3
40
$425.08
$17.00K
13,786
Direct
SaleMar 6, 2026
Common StockF3F4
420
$426.8638
$179.28K
13,366
Direct
SaleMar 6, 2026
Common StockF3F5
80
$427.845
$34.23K
13,286
Direct
SaleMar 6, 2026
Common StockF3F6
160
$428.995
$68.64K
13,126
Direct
SaleMar 6, 2026
Common StockF3
40
$429.58
$17.18K
13,086
Direct
SaleMar 6, 2026
Common StockF3F7
120
$430.9033
$51.71K
12,966
Direct
SaleMar 6, 2026
Common StockF3F8
116
$432.5559
$50.18K
12,850
Direct
SaleMar 6, 2026
Common StockF3F9
160
$434.20
$69.47K
12,690
Direct
SaleMar 6, 2026
Common StockF3F10
80
$435.315
$34.83K
12,610
Direct
SaleMar 6, 2026
Common StockF3F11
80
$436.69
$34.94K
12,530
Direct
SaleMar 6, 2026
Common StockF3
40
$437.65
$17.51K
12,490
Direct
Filing footnotes · 12
F1Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $435.26 to $435.37, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.46 to $436.92, inclusive.
F12The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
F2This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F3These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.46 to $427.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.50 to $428.19, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.51 to $429.24, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.66 to $431.04, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.41 to $432.99, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.82 to $434.58, inclusive.
Filed Mar 6, 2026Period of report Mar 4, 20260001628280-26-015769
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF2
1,663
$431.94
$718.32K
161,829
Direct
Filing footnotes · 3
F1Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
F2This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F3The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Filed Mar 6, 2026Period of report Mar 4, 20260001628280-26-015763
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF2
360
$431.94
$155.50K
12,138
Direct
Filing footnotes · 3
F1Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
F2This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F3The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Filed Mar 6, 2026Period of report Mar 4, 20260001628280-26-015758
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF2
419
$431.94
$180.98K
12,692
Direct
Filing footnotes · 3
F1Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
F2This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F3The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Filed Mar 6, 2026Period of report Mar 6, 20260001628280-26-015736
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF1
491
$431.94
$212.08K
452,213
Direct
Filing footnotes · 2
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F2The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Filed Mar 2, 2026Period of report Mar 2, 20260001628280-26-013394
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
1,183
$427.21
$505.39K
9,257
Direct
Filing footnotes · 1
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
Filed Jan 26, 2026Period of report Jan 26, 20260001628280-26-003482
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 26, 2026
Common StockF1
340
$492.42
$167.42K
9,692
Direct
SaleJan 26, 2026
Common StockF2
570
$494.59
$281.92K
9,122
Direct
Filing footnotes · 2
F1The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F2This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
Filed Jan 26, 2026Period of report Jan 26, 20260001628280-26-003468
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 26, 2026
Common StockF1
1,577
$492.42
$776.55K
148,497
Direct
Filing footnotes · 1
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
Filed Jan 26, 2026Period of report Jan 26, 20260001628280-26-003452
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 26, 2026
Common StockF1
647
$492.42
$318.60K
452,704
Direct
Filing footnotes · 2
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F2The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Filed Jan 20, 2026Period of report Jan 20, 20260001628280-26-002742
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 20, 2026
Common StockF1
263
$490.77
$129.07K
8,910
Direct
SaleJan 20, 2026
Common StockF2
429
$501.40
$215.10K
8,481
Direct
Filing footnotes · 2
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F2This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.
Filed Jan 20, 2026Period of report Jan 20, 20260001628280-26-002735
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 20, 2026
Common StockF1
2,238
$490.77
$1.10M
453,351
Direct
Filing footnotes · 2
F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F2The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Filed Jan 13, 2026Period of report Jan 9, 20260001628280-26-001981
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 9, 2026
Common StockF1F2
280
$551.2414
$154.35K
187,164
Direct
Filing footnotes · 4
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.24 to $551.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The Reporting Person and his spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4The shares underlying this stock option are fully vested and exercisable.
Filed Jan 13, 2026Period of report Jan 9, 20260001628280-26-001976
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 9, 2026
Common StockF1F2
1,480
$511.9774
$757.73K
210,204
Direct
SaleJan 9, 2026
Common StockF1F3
1,094
$513.1079
$561.34K
209,110
Direct
SaleJan 9, 2026
Common StockF1F4
1,345
$514.681
$692.25K
207,765
Direct
SaleJan 9, 2026
Common StockF1F5
1,996
$515.8123
$1.03M
205,769
Direct
SaleJan 9, 2026
Common StockF1F6
766
$516.8356
$395.90K
205,003
Direct
SaleJan 9, 2026
Common StockF1F7
2,450
$517.8591
$1.27M
202,553
Direct
SaleJan 9, 2026
Common StockF1F8
1,363
$518.6837
$706.97K
201,190
Direct
SaleJan 9, 2026
Common StockF1F9
846
$519.8838
$439.82K
200,344
Direct
SaleJan 9, 2026
Common StockF1F10
681
$521.0327
$354.82K
199,663
Direct
SaleJan 9, 2026
Common StockF1F11
840
$521.9779
$438.46K
198,823
Direct
SaleJan 9, 2026
Common StockF1F12
970
$522.9972
$507.31K
197,853
Direct
SaleJan 9, 2026
Common StockF1F13
1,199
$524.0986
$628.39K
196,654
Direct
SaleJan 9, 2026
Common StockF1F14
2,432
$525.0475
$1.28M
194,222
Direct
SaleJan 9, 2026
Common StockF1F15
1,066
$526.0005
$560.72K
193,156
Direct
SaleJan 9, 2026
Common StockF1F16
1,560
$526.9685
$822.07K
191,596
Direct
SaleJan 9, 2026
Common StockF1F17
575
$528.1777
$303.70K
191,021
Direct
SaleJan 9, 2026
Common StockF1F18
691
$529.1654
$365.65K
190,330
Direct
SaleJan 9, 2026
Common StockF1F19
166
$529.7624
$87.94K
190,164
Direct
SaleJan 9, 2026
Common StockF1F20
280
$530.6871
$148.59K
189,884
Direct
SaleJan 9, 2026
Common StockF1
80
$532.50
$42.60K
189,804
Direct
SaleJan 9, 2026
Common StockF1F21
332
$534.1638
$177.34K
189,472
Direct
SaleJan 9, 2026
Common StockF1F22
148
$535.2886
$79.22K
189,324
Direct
SaleJan 9, 2026
Common StockF1F23
473
$536.0206
$253.54K
188,851
Direct
SaleJan 9, 2026
Common StockF1F24
487
$536.8768
$261.46K
188,364
Direct
SaleJan 9, 2026
Common StockF1F25
80
$537.845
$43.03K
188,284
Direct
SaleJan 9, 2026
Common StockF1F26
480
$539.2317
$258.83K
187,804
Direct
SaleJan 9, 2026
Common StockF1F27
600
$540.358
$324.21K
187,204
Direct
SaleJan 9, 2026
Common StockF1
40
$545.79
$21.83K
187,164
Direct
Filing footnotes · 29
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.48 to $521.45, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.49 to $522.40, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.49 to $523.46, inclusive.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.51 to $524.48, inclusive.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.51 to $525.49, inclusive.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.55 to $526.50, inclusive.
F16The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.56 to $527.51, inclusive.
F17The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.56 to $528.53, inclusive.
F18The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.56 to $529.52, inclusive.
F19The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.56 to $530.12, inclusive.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F20The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.63 to $531.03, inclusive.
F21The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.54, inclusive.
F22The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $535.57, inclusive.
F23The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.57, inclusive.
F24The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.11, inclusive.
F25The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.83 to $537.86, inclusive.
F26The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.42, inclusive.
F27The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.25 to $540.38, inclusive.
F28The Reporting Person and his spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F29The shares underlying this stock option are fully vested and exercisable.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $512.77 to $513.60, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.28 to $515.22, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.29 to $516.21, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.34 to $517.28, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.38 to $519.37, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.42, inclusive.
Filed Jan 13, 2026Period of report Jan 9, 20260001628280-26-001970
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 9, 2026
Common StockF1
40
$545.79
$21.83K
455,789
Direct
SaleJan 9, 2026
Common StockF1F2
200
$551.242
$110.25K
455,589
Direct
Filing footnotes · 4
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.24 to $551.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4The shares underlying this stock option are fully vested and exercisable.
Filed Jan 13, 2026Period of report Jan 9, 20260001628280-26-001961
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 9, 2026
Common StockF1F2
960
$512.0179
$491.54K
473,039
Direct
SaleJan 9, 2026
Common StockF1F3
960
$513.1196
$492.59K
472,079
Direct
SaleJan 9, 2026
Common StockF1F4
937
$514.6291
$482.21K
471,142
Direct
SaleJan 9, 2026
Common StockF1F5
1,578
$515.8228
$813.97K
469,564
Direct
SaleJan 9, 2026
Common StockF1F6
521
$516.8085
$269.26K
469,043
Direct
SaleJan 9, 2026
Common StockF1F7
2,044
$517.8415
$1.06M
466,999
Direct
SaleJan 9, 2026
Common StockF1F8
970
$518.6658
$503.11K
466,029
Direct
SaleJan 9, 2026
Common StockF1F9
539
$519.8879
$280.22K
465,490
Direct
SaleJan 9, 2026
Common StockF1F10
440
$521.1112
$229.29K
465,050
Direct
SaleJan 9, 2026
Common StockF1F11
588
$521.9535
$306.91K
464,462
Direct
SaleJan 9, 2026
Common StockF1F12
732
$522.9817
$382.82K
463,730
Direct
SaleJan 9, 2026
Common StockF1F13
1,335
$524.062
$699.62K
462,395
Direct
SaleJan 9, 2026
Common StockF1F14
1,489
$525.1196
$781.90K
460,906
Direct
SaleJan 9, 2026
Common StockF1F15
913
$526.0475
$480.28K
459,993
Direct
SaleJan 9, 2026
Common StockF1F16
1,135
$526.9523
$598.09K
458,858
Direct
SaleJan 9, 2026
Common StockF1F17
465
$528.1562
$245.59K
458,393
Direct
SaleJan 9, 2026
Common StockF1F18
554
$529.2813
$293.22K
457,839
Direct
SaleJan 9, 2026
Common StockF1F19
256
$530.4525
$135.80K
457,583
Direct
SaleJan 9, 2026
Common StockF1
30
$531.05
$15.93K
457,553
Direct
SaleJan 9, 2026
Common StockF1
40
$532.50
$21.30K
457,513
Direct
SaleJan 9, 2026
Common StockF1F20
271
$534.1751
$144.76K
457,242
Direct
SaleJan 9, 2026
Common StockF1F21
89
$534.9324
$47.61K
457,153
Direct
SaleJan 9, 2026
Common StockF1F22
299
$535.8041
$160.21K
456,854
Direct
SaleJan 9, 2026
Common StockF1F23
385
$536.8832
$206.70K
456,469
Direct
SaleJan 9, 2026
Common StockF1
40
$537.84
$21.51K
456,429
Direct
SaleJan 9, 2026
Common StockF1F24
400
$539.264
$215.71K
456,029
Direct
SaleJan 9, 2026
Common StockF1
40
$540.26
$21.61K
455,989
Direct
SaleJan 9, 2026
Common StockF1
400
$542.72
$217.09K
455,589
Direct
Filing footnotes · 26
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.46 to $521.45, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.50 to $522.49, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.51 to $523.47, inclusive.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.59 to $524.58, inclusive.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.59 to $525.56, inclusive.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.59 to $526.55, inclusive.
F16The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.63 to $527.58, inclusive.
F17The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.71 to $528.52, inclusive.
F18The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.72 to $529.69, inclusive.
F19The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.97 to $530.63, inclusive.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F20The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.57, inclusive.
F21The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $534.99, inclusive.
F22The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.32, inclusive.
F23The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.30, inclusive.
F24The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.44, inclusive.
F25The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F26The shares underlying this stock option are fully vested and exercisable.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.00 to $513.58, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.32 to $515.25, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.32 to $516.29, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.32 to $517.26, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.39 to $519.29, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.38, inclusive.
Filed Dec 12, 2025Period of report Dec 10, 20250001628280-25-056794
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 10, 2025
Common StockF1F2
624
$547.7462
$341.79K
211,340
Direct
SaleDec 10, 2025
Common StockF1F3
535
$548.5067
$293.45K
210,805
Direct
SaleDec 10, 2025
Common StockF1F4
409
$549.9871
$224.94K
210,396
Direct
SaleDec 10, 2025
Common StockF1F5
4,316
$550.9328
$2.38M
206,080
Direct
SaleDec 10, 2025
Common StockF1F6
7,193
$551.6653
$3.97M
198,887
Direct
SaleDec 10, 2025
Common StockF1F7
5,533
$552.7439
$3.06M
193,354
Direct
SaleDec 10, 2025
Common StockF1F8
5,001
$553.8349
$2.77M
188,353
Direct
SaleDec 10, 2025
Common StockF1F9
1,029
$554.9963
$571.09K
187,324
Direct
SaleDec 10, 2025
Common StockF1
160
$555.39
$88.86K
187,164
Direct
Filing footnotes · 11
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F10The Reporting Person and his spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F11The shares underlying this stock option are fully vested and exercisable.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.17 to $548.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.17 to $549.08, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.27 to $550.23, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.28 to $551.26, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.28 to $552.26, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.28 to $553.27, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.28 to $554.27, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.39 to $555.31, inclusive.
Filed Dec 12, 2025Period of report Dec 10, 20250001628280-25-056792
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 10, 2025
Common StockF1F2
491
$547.7567
$268.95K
479,203
Direct
SaleDec 10, 2025
Common StockF1F3
369
$548.5579
$202.42K
478,834
Direct
SaleDec 10, 2025
Common StockF1F4
486
$550.0715
$267.33K
478,348
Direct
SaleDec 10, 2025
Common StockF1F5
4,723
$550.9861
$2.60M
473,625
Direct
SaleDec 10, 2025
Common StockF1F6
4,410
$551.8461
$2.43M
469,215
Direct
SaleDec 10, 2025
Common StockF1F7
3,857
$552.8122
$2.13M
465,358
Direct
SaleDec 10, 2025
Common StockF1F8
3,087
$553.8795
$1.71M
462,271
Direct
SaleDec 10, 2025
Common StockF1F9
1,027
$554.8417
$569.82K
461,244
Direct
SaleDec 10, 2025
Common StockF1
200
$555.39
$111.08K
461,044
Direct
Filing footnotes · 12
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
F10The Reporting Person made a charitable contribution of 5,455 shares of common stock of the Issuer to a donor advised fund.
F11The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F12The shares underlying this stock option are fully vested and exercisable.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.16 to $548.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.17 to $549.00, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.38 to $550.37, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.39 to $551.38, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.39 to $552.38, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.39 to $553.38, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.39 to $554.33, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.39 to $555.31, inclusive.
Filed Dec 4, 2025Period of report Dec 3, 20250001628280-25-055430
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 4, 2025
Common StockF2
2,400
$575.34
$1.38M
150,074
Direct
Filing footnotes · 3
F1On December 3, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 3. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2028, the fifth anniversary of the commencement of his employment with the Issuer.
F2The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover certain tax withholding obligations in connection with the Reporting Person earning 50,000 shares of common stock as described in Footnote 1 above. This sale was automatic and not at the discretion of the Reporting Person.
F3On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award. Following the achievement of the first hurdle in February 2025 and the second hurdle reported on this line, the Reporting Person is eligible to earn an additional 50,000 shares upon the achievement of the final performance hurdle. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the Performance Restricted Stock Units.
Filed Dec 3, 2025Period of report Dec 2, 20250001628280-25-055164
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 2, 2025
Common StockF1F2
320
$570.386
$182.52K
14,293
Direct
SaleDec 2, 2025
Common StockF1F3
410
$571.9892
$234.52K
13,883
Direct
SaleDec 2, 2025
Common StockF1F4
354
$573.0151
$202.85K
13,529
Direct
SaleDec 2, 2025
Common StockF1F5
717
$574.0011
$411.56K
12,812
Direct
SaleDec 2, 2025
Common StockF1F6
120
$574.9524
$68.99K
12,692
Direct
SaleDec 2, 2025
Common StockF1F7
240
$576.1517
$138.28K
12,452
Direct
SaleDec 2, 2025
Common StockF1F8
320
$577.8144
$184.90K
12,132
Direct
SaleDec 2, 2025
Common StockF1F9
258
$578.831
$149.34K
11,874
Direct
SaleDec 2, 2025
Common StockF1F10
480
$579.8525
$278.33K
11,394
Direct
SaleDec 2, 2025
Common StockF1F11
240
$585.4383
$140.51K
11,154
Direct
SaleDec 2, 2025
Common StockF1F12
240
$587.8495
$141.08K
10,914
Direct
SaleDec 2, 2025
Common StockF1F13
160
$589.6479
$94.34K
10,754
Direct
SaleDec 2, 2025
Common StockF1F14
160
$590.3725
$94.46K
10,594
Direct
SaleDec 2, 2025
Common StockF1F15
74
$595.2047
$44.05K
10,520
Direct
SaleDec 2, 2025
Common StockF1F16
80
$596.185
$47.69K
10,440
Direct
Filing footnotes · 17
F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.59 to $580.46, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.08 to $585.99, inclusive.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $587.58 to $588.07, inclusive.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.13 to $589.96, inclusive.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.15 to $590.58, inclusive.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.18 to $595.41, inclusive.
F16The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.18 to $596.19, inclusive.
F17All shares issued pursuant to the exercise of the options reported herein represent 4,173 shares underlying an overall option award of 13,353 shares. All exercised options had vested. As to the overall option for 13,353 shares, 25% of the shares vested on March 1, 2025, and, thereafter, 6.25% of the shares vested or will vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.17 to $570.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.45 to $572.34, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.48 to $573.38, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.59 to $574.44, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.67 to $575.24, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.69 to $576.46, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.36 to $578.31, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.37 to $579.20, inclusive.
Filed Nov 21, 2025Period of report Nov 21, 20250001628280-25-053648
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 21, 2025
Common StockF1
894
$550.97
$492.57K
11,096
Direct
SaleNov 21, 2025
Common StockF2F3
144
$547.2683
$78.81K
10,952
Direct
SaleNov 21, 2025
Common StockF2F4
120
$548.71
$65.85K
10,832
Direct
SaleNov 21, 2025
Common StockF2F5
40
$549.3425
$21.97K
10,792
Direct
SaleNov 21, 2025
Common StockF2F6
200
$552.384
$110.48K
10,592
Direct
SaleNov 21, 2025
Common StockF2F7
40
$553.2283
$22.13K
10,552
Direct
SaleNov 21, 2025
Common StockF2F8
120
$556.04
$66.72K
10,432
Direct
SaleNov 21, 2025
Common StockF2F9
200
$559.598
$111.92K
10,232
Direct
SaleNov 21, 2025
Common StockF2F10
80
$560.62
$44.85K
10,152
Direct
SaleNov 21, 2025
Common StockF2
40
$563.21
$22.53K
10,112
Direct
SaleNov 21, 2025
Common StockF2F11
80
$564.565
$45.17K
10,032
Direct
Filing footnotes · 11
F1The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.24 to $561.00, inclusive.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.55 to $564.58, inclusive.
F2These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.12 to $547.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.25 to $548.94, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.30 to $549.38, inclusive.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.96 to $552.81, inclusive.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.22 to $553.23, inclusive.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.74 to $556.19, inclusive.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $559.22 to $560.06, inclusive.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.